<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04549298</url>
  </required_header>
  <id_info>
    <org_study_id>LMB09</org_study_id>
    <nct_id>NCT04549298</nct_id>
  </id_info>
  <brief_title>Assessment of the Possible Association Between Left Ventricular Diastolic Dysfunction and Carotid Atherosclerosis and Brain White Matter Damage</brief_title>
  <official_title>Assessment of the Possible Association Between Left Ventricular Diastolic Dysfunction and Carotid Atherosclerosis and Brain White Matter Damage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuromed IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuromed IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left ventricular diastolic dysfunction is caused by impaired relaxation and increased left&#xD;
      ventricular stiffness with a consequent increase in filling pressures. Currently, it is&#xD;
      possible to classify it in 3 grades: grade 1 with normal filling pressures, grade 2 and grade&#xD;
      3 with high pressures. Diastolic dysfunction is closely associated with several risk factors&#xD;
      such as hypertension, diabetes, and obesity, as well as the risk of heart failure,&#xD;
      cardiovascular events, and death. In the field of cerebrovascular diseases, however,&#xD;
      diastolic dysfunction is still being researched. Thus, this study aims to: 1) evaluate the&#xD;
      white matter hyperintensities volume in association with the increase of diastolic&#xD;
      dysfunction and filling pressures 2) evaluate the possible association with carotid&#xD;
      atherosclerosis in case of brain damage caused by dysfunction diastolic 3) understand the&#xD;
      mechanism of damage caused by left ventricular diastolic dysfunction on the cerebrovascular&#xD;
      system. In order to do this, this study proposes to evaluate in a cohort of patients, between&#xD;
      35 and 65 years, the possible association of diastolic dysfunction with lesions on the&#xD;
      cerebrovascular system in a future view of new marker of brain damage and new modifiable risk&#xD;
      factor.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of white matter hyperintensities volume</measure>
    <time_frame>At Enrollment</time_frame>
    <description>Brain MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of plaques and carotid atherosclerosis</measure>
    <time_frame>At Enrollment</time_frame>
    <description>Ultrasound of the supraortic trunks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of cardiac overload with blood markers</measure>
    <time_frame>At Enrollment</time_frame>
    <description>NT-proBNP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of cognitive decline by decrease of MoCA score</measure>
    <time_frame>At Enrollment</time_frame>
    <description>Cognitive tests</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Left Ventricular Diastolic Dysfunction</condition>
  <arm_group>
    <arm_group_label>Patients with grade 2 and 3 LV diastolic dysfunction</arm_group_label>
    <description>Patients with high filling pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with normal and grade 1 LV diastolic dysfunction</arm_group_label>
    <description>Patients with normal filling pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No interventions</intervention_name>
    <description>No interventions - observational study</description>
    <arm_group_label>Patients with grade 2 and 3 LV diastolic dysfunction</arm_group_label>
    <arm_group_label>Patients with normal and grade 1 LV diastolic dysfunction</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from patients attending the Department of AngioCardioNeurology of&#xD;
        the IRCCS Neuromed, accordingly to the following inclusion/exclusion criteria.&#xD;
        Approximately 88 subjects of both genders will be included in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ≥ 35 and ≤ 65 years&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous stroke or TIA&#xD;
&#xD;
          -  arrhythmia or severe cardiac disease&#xD;
&#xD;
          -  renal disease&#xD;
&#xD;
          -  psychiatric disease&#xD;
&#xD;
          -  neurological or neurodegenerative disease&#xD;
&#xD;
          -  dementia&#xD;
&#xD;
          -  previous carotid artery stenting or carotid surgery&#xD;
&#xD;
          -  inability to be subjected MRI analysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giuseppe Lembo, MD, PhD</last_name>
    <phone>+390865915225</phone>
    <email>lembo@neuromed.it</email>
  </overall_contact>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuromed IRCCS</investigator_affiliation>
    <investigator_full_name>Giuseppe Lembo</investigator_full_name>
    <investigator_title>Full Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Diastolic dysfunction</keyword>
  <keyword>White matter hyperintensities</keyword>
  <keyword>Carotid atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

